Lovshin JA, Bjornstad P, Lovblom LE, Bai JW, Lytvyn Y, Boulet G, et al. Atherosclerosis and microvascular complications: results from the Canadian study of longevity in Type 1 diabetes. Diabetes Care. 2018;41(12):2570–8.
Google Scholar
Colom C, Rull A, Sanchez-Quesada JL, Pérez A. Cardiovascular disease in Type 1 diabetes mellitus: epidemiology and management of cardiovascular risk. J Clin Med. 2021;10(8):1798.
Google Scholar
Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson AM, Miftaraj M, et al. Range of risk factor levels: control, mortality, and cardiovascular outcomes in Type 1 diabetes mellitus. Circulation. 2017;135(16):1522–31.
Google Scholar
Lind M, Svensson AM, Kosiborod M, Gudbjörnsdottir S, Pivodic A, Wedel H, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371(21):1972–82.
Google Scholar
Rawshani A, Sattar N, Franzén S, Rawshani A, Hattersley AT, Svensson AM, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018;392(10146):477–86.
Google Scholar
Vergès B. Cardiovascular disease in type 1 diabetes: a review of epidemiological data and underlying mechanisms. Diabetes Metab. 2020;46(6):442–9.
Google Scholar
Holte KB, Svanteson M, Hanssen KF, Haig Y, Solheim S, Berg TJ. Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study J Diabetes Complications. 2019;33(5):383–9.
Google Scholar
Eid S, Sas KM, Abcouwer SF, Feldman EL, Gardner TW, Pennathur S, et al. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism. Diabetologia. 2019;62(9):1539–49.
Google Scholar
Vergès B. Lipid disorders in type 1 diabetes. Diabetes Metab. 2009;35(5):353–60.
Google Scholar
Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–53.
Google Scholar
Rawshani A, Rawshani A, Sattar N, Franzén S, McGuire DK, Eliasson B, et al. Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in Type 1 diabetes mellitus. Circulation. 2019;139(16):1900–12.
Google Scholar
Vergès B. Dyslipidemia in Type 1 diabetes: AMaskedDanger. Trends Endocrinol Metab. 2020;31(6):422–34.
Google Scholar
Ahmed MO, Byrne RE, Pazderska A, Segurado R, Guo W, Gunness A, et al. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study. Diabetologia. 2021;64(3):656–67.
Google Scholar
Nikkilä EA, Kekki M. Plasma triglyceride transport kinetics in diabetes mellitus. Metabolism. 1973;22(1):1–22.
Google Scholar
Dullaart RP. Plasma lipoprotein abnormalities in type 1 (insulin-dependent) diabetes mellitus. Neth J Med. 1995;46(1):44–54.
Google Scholar
Lipid and lipoprotein levels in patients with IDDM diabetes control and complication. Trial experience. The DCCT Research Group. Diabetes Care. 199215(7):886–94.
Marcovecchio ML, Dalton RN, Prevost AT, Acerini CL, Barrett TG, Cooper JD, et al. Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes. Diabetes Care. 2009;32(4):658–63.
Google Scholar
Amor AJ, Castelblanco E, Hernández M, Gimenez M, Granado-Casas M, Blanco J, et al. Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles. Cardiovasc Diabetol. 2020;19(1):126.
Google Scholar
Serés-Noriega T, Perea V, Amor AJ. Screening for subclinical atherosclerosis and the prediction of cardiovascular events in people with Type 1 diabetes. J Clin Med. 2024;13(4):1097.
Google Scholar
Holte KB, Juel NG, Brox JI, Hanssen KF, Fosmark DS, Sell DR, et al. Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products. The Dialong study J Diabetes Comp. 2017;31(9):1408–14.
Svanteson M, Holte KB, Haig Y, Kløw NE, Berg TJ. Coronary plaque characteristics and epicardial fat tissue in long term survivors of type 1 diabetes identified by coronary computed tomography angiography. Cardiovasc Diabetol. 2019;18(1):58.
Google Scholar
Soininen P, Kangas AJ, Würtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 2015;8(1):192–206.
Google Scholar
Soininen P, Kangas AJ, Würtz P, Tukiainen T, Tynkkynen T, Laatikainen R, et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 2009;134(9):1781–5.
Google Scholar
Holmes MV, Millwood IY, Kartsonaki C, Hill MR, Bennett DA, Boxall R, et al. Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke. J Am Coll Cardiol. 2018;71(6):620–32.
Google Scholar
Holte KB, Svanteson M, Hanssen KF, Sveen KA, Seljeflot I, Solheim S, et al. Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study PLoS One. 2020;15(5): e0233174.
Google Scholar
Larsen J, Brekke M, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K. Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes. 2002;51(8):2637–41.
Google Scholar
Sveen KA, Bech Holte K, Svanteson M, Hanssen KF, Nilsson J, Bengtsson E, et al. Autoantibodies against methylglyoxal-modified apolipoprotein B100 and ApoB100 peptide are associated with less coronary artery atherosclerosis and retinopathy in long-term Type 1 diabetes. Diabetes Care. 2021;44(6):1402–9.
Google Scholar
Llauradó G, Amigó N, Fuertes-Martín R, Romero A, Cano A, Albert L, et al. Measurement of serum N-glycans in the assessment of early vascular aging (arterial stiffness) in adults with Type 1 diabetes. Diabetes Care. 2022;45(10):2430–8.
Google Scholar
Puig-Jové C, Julve J, Castelblanco E, Julián MT, Amigó N, Andersen HU, et al. The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus. Cardiovasc Diabetol. 2022;21(1):257.
Google Scholar
Serés-Noriega T, Giménez M, Perea V, Blanco J, Vinagre I, Pané A, et al. Quantification of glycoproteins by nuclear magnetic resonance associated with preclinical carotid atherosclerosis in patients with type 1 diabetes. Nutr Metab Cardiovasc Dis. 2021;31(7):2099–108.
Google Scholar
Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes. 2002;51(6):1949–56.
Google Scholar
Cree-Green M, Maahs DM, Ferland A, Hokanson JE, Wang H, Pyle L, et al. Lipoprotein subfraction cholesterol distribution is more atherogenic in insulin resistant adolescents with type 1 diabetes. Pediatr Diabetes. 2016;17(4):257–65.
Google Scholar
Basu A, Jenkins AJ, Zhang Y, Stoner JA, Klein RL, Lopes-Virella MF, et al. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes. Atherosclerosis. 2016;244:93–100.
Google Scholar
Colom C, Viladés D, Pérez-Cuellar M, Leta R, Rivas-Urbina A, Carreras G, et al. Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes. Cardiovasc Diabetol. 2018;17(1):156.
Google Scholar
Costacou T, Miller RG, Bornfeldt KE, Heinecke JW, Orchard TJ, Vaisar T. Sex differences in the associations of HDL particle concentration and cholesterol efflux capacity with incident coronary artery disease in type 1 diabetes: the retro HDLc cohort study. J Clin Lipidol. 2024;18(2):e218–29.
Google Scholar
Costacou T, Vaisar T, Miller RG, Davidson WS, Heinecke JW, Orchard TJ, et al. High-density lipoprotein particle concentration and size predict incident coronary artery disease events in a cohort with Type 1 diabetes. J Am Heart Assoc. 2024;13(14): e034763.
Google Scholar
Serés-Noriega T, Ortega E, Giménez M, Perea V, Boswell L, Mariaca K, et al. Advanced lipoprotein profile identifies atherosclerosis better than conventional lipids in type 1 diabetes at high cardiovascular risk. Nutr Metab Cardiovasc Dis. 2023;33(6):1235–44.
Google Scholar
Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med. 2007;357(13):1301–10.
Google Scholar
Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet. 2014;384(9943):618–25.
Google Scholar
Melnes T, Bogsrud MP, Thorsen I, Fossum J, Christensen JJ, Narverud I, et al. What characterizes event-free elderly FH patients? A comprehensive lipoprotein profiling. Nutr Metab Cardiovasc Dis. 2022;32(7):1651–60.
Google Scholar
Chou R, Cantor A, Dana T, Wagner J, Ahmed AY, Fu R, et al. Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US preventive services task force. JAMA. 2022;328(8):754–71.
Google Scholar
Wang W, van Dijk KW, Wijsman CA, Rozing MP, Mooijaart SP, Beekman M, et al. Differential insulin sensitivity of NMR-based metabolomic measures in a two-step hyperinsulinemic euglycemic clamp study. Metabolomics. 2021;17(6):57.
Google Scholar
Chait A, Eckel RH, Vrablik M, Zambon A. Lipid-lowering in diabetes: an update. Atherosclerosis. 2024;394: 117313.
Google Scholar
Lan NSR, Hong RSY, Ryan C, Jenkins AJ, Fegan PG. Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes. Prim Care Diabetes. 2023;17(5):526–8.
Google Scholar
Lan NSR, Yeap BB, Bell DA, Watts GF, Fegan PG. Patients with type 1 diabetes in a tertiary setting do not attain recommended lipid targets. Diabetes Metab. 2020;46(4):339–41.
Google Scholar
Wadwa RP, Kinney GL, Maahs DM, Snell-Bergeon J, Hokanson JE, Garg SK, et al. Awareness and treatment of dyslipidemia in young adults with Type 1 diabetes. Diabetes Care. 2005;28(5):1051–6.
Google Scholar